Samjin Pharmaceutical Launches Fast-Acting Liquid Cold Medicine 'Lacold Syrup'

Samjin Pharmaceutical announced on November 14 that it will launch two new products for the flu season-'Lacold Total Syrup' and 'Lacold Cough Syrup'-which allow for tailored responses to patients' specific symptoms.

Lacold Total Syrup contains a combination of acetaminophen (antipyretic and analgesic), guaifenesin (expectorant), DL-methylephedrine hydrochloride (antitussive), dextromethorphan (antitussive), and chlorpheniramine (antihistamine), making it effective for alleviating a wide range of cold symptoms such as fever, cough, phlegm, runny nose, and sore throat.

Samjin Pharmaceutical Lacold Syrup product. Samjin Pharmaceutical

Lacold Cough Syrup features a specialized formulation for relieving cough and phlegm, focusing on respiratory symptom relief with guaifenesin and antitussive ingredients as its main components.

Notably, 'Lacold (Lock-cold)' is a syrup formulation with higher viscosity than standard liquid forms, allowing the active ingredients to stay on the throat mucosa for a longer period and thus providing more effective cough suppression and sore throat relief. To address the characteristic bitterness of acetaminophen, orange flavor has been added, improving palatability for both children and adults. Additionally, the product name 'Lacold (Lock-cold)' conveys the idea of 'locking' the cold, and the packaging design incorporates imagery reminiscent of a thermometer, enabling consumers to intuitively recognize Lacold as a cold medicine.

A representative from Samjin Pharmaceutical stated, "The two types of Lacold syrup, launched for the flu season, are expected to further strengthen our competitiveness in the pharmacy market by focusing on two key elements: improved dosing convenience and efficacy. With a product lineup tailored to different symptoms, we plan to actively target the cold medicine market through these new offerings."

This content was produced with the assistance of AI translation services.